SynAct Pharma AB · GETTEX:8F8

SynAct Pharma AB insider trades

SynAct Pharma AB's insiders made 10 buys and 2 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

Insider trades

TradeTradeSharesPriceValueDate
Quantass ApS
Closely associated with Jeppe Øvlesen (Chief Executive Officer (CEO)/Managing Directory)
Buy20,313SEK 14.25SEK 289KNov 16, 2026
TJ Biotech Holding ApS
Closely associated with Thomas Jonassen (Other senior executive)
Sale350,000SEK 17.80SEK 6.23MSep 2, 2026
Quantass ApS
Closely associated with Jeppe Øvlesen (Chief Executive Officer (CEO)/Managing Directory)
Sale150,000SEK 17.80SEK 2.67MSep 2, 2026
Anders Kronborg
Chairman of the Board of Directors
Buy2,750SEK 18.12SEK 49,830Mar 10, 2026
Quantass ApS
Closely associated with Jeppe Øvli Øvlesen (Chief Executive Officer (CEO)/Managing Directory)
Buy7,900SEK 17.99SEK 142KMar 5, 2026
Mads Liebach Bjerregaard
Other member of the company's administrative, management or supervisory body
Buy1,500SEK 17.92SEK 26,880Mar 5, 2026
Boesen Biotech ApS
Closely associated with Thomas Boesen (Other member of the company's administrative, management or supervisory body)
Buy2,700SEK 17.90SEK 48,330Mar 3, 2026
Boesen Biotech ApS
Closely associated with Thomas Boesen (Other member of the company's administrative, management or supervisory body)
Buy2,750SEK 17.92SEK 49,280Mar 3, 2026
TJ Biotech Holding ApS
Closely associated with Thomas Jonassen (Other senior executive)
Buy3,529SEK 20.45SEK 72,168Dec 19, 2025
Anders Kronborg
Chairman of the Board of Directors
Buy3,470SEK 20.84SEK 72,301Dec 19, 2025
Mads Liebach Bjerregaard
Other member of the company's administrative, management or supervisory body
Buy1,500SEK 20.35SEK 30,525Dec 17, 2025
Quantass ApS
Chief Executive Officer (CEO)/Managing Directory
Buy3,529SEK 20.24SEK 71,429Dec 17, 2025

SynAct Pharma AB shareholders